TBPMF News and Press, Tetra Bio-Pharma Inc

2023-08-01 10:20:43 ET Tetra Bio-Pharma ( TSX: TBP:CA ) ( OTCPK:TBPMF ) has voluntarily declared bankruptcy in Canada, the company said Tuesday. HOULEROY S.A. has been appointed as the company's trustee in bankruptcy. On March 7, 2023, the Ontario Securities Comm...

(TheNewswire) Montreal – TheNewswire - August 1, 2023 – Tetra Bio-Pharma Inc. (“ Tetra ” or the “ Company ”) ( TSX:TBP ) ( OTC:TBPMF ) (FRA:JAM1) a leader in cannabinoid-derived drug discovery and development announced that...

(TheNewswire) MONTREAL, QUEBEC – TheNewswire – May 11, 2023 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTC:TBPMF) (FRA:JAM1), a leader in cannabinoid-derived drug discovery and development, today announced it has cancelled its New Drug Subm...

(TheNewswire) Montreal, QC - TheNewswire - March 10, 2023 - Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX:TBP) (OTC:TBPMF) (FRA:JAM1) , a leader in cannabinoid-derived drug discovery and development is pleased to announce Health Canada h...

(TheNewswire) MONTREAL, QUEBEC – TheNewswire – March 7, 2023 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTC:TBPMF) (FRA:JAM1), a leader in cannabinoid-derived drug discovery and development announces that further to its press release dated March 1, 2023, the ...

--News Direct-- The Company is receiving up to $150,000 in funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support the development of its novel oral therapeutic for systemic hyperinflammation. MONTREAL, QUEBEC – TheN...

(TheNewswire) MONTREAL, QUEBEC – TheNewswire – March 1, 2023 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTC-PINK: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development, announced today that it will not be in ...

Tetra Bio-Pharma Announces Listing to OTCPink Market Canada NewsWire MONTREAL , Feb. 10, 2023 /CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTC-PINK: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development, to...

REDUVO™ Marketing Approval on the Right Path Canada NewsWire Second Clarifax received from Health Canada. MONTREAL , Dec. 22, 2022 /CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1) a leader in cannabinoi...

Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir Canada NewsWire The combination of ARDS-003 and Favipiravir presents viable treatments against viral infections. Results from the PIONEER clinical trial ...